Should we already deal with lipoprotein(a) in clinical practice?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Should we already deal with lipoprotein(a) in clinical practice?

Published:2024-05-06 Issue:3 Volume:70 Page:152-156
ISSN:0042-773X
Container-title:Vnitřní lékařství
language:
Short-container-title:Vnitř Lék

Author:

Vantová Zuzana,Mayer Otto

Publisher

Solen s.r.o.

Link

http://casopisvnitrnilekarstvi.cz/doi/10.36290/vnl.2024.032.pdf

Reference32 articles.

1. A NEW SERUM TYPE SYSTEM IN MAN-THE Lp SYSTEM

2. Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of cardiology, European atherosclerosis Society and European society of Hypertension

3. Lipoprotein(a) as a cardiovascular risk factor: current status

4. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

5. Stanovisko ČSAT ke Konsenzu Evropské společnosti pro aterosklerózu: Lipoprotein(a) při aterosklerotických kardiovaskulárních onemocněních a aortální stenóze;Vrablík;AtheroRev,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP